Identification of trimeric peptides that bind porcine parvovirus from mixtures containing human blood plasma

Biotechnology Progress

Volumn 24, Issue 3, 2008, Pages 554-560

  Heldt, Caryn L ^a   Gurgel, Patrick V ^a,c   Jaykus, Lee Ann ^b   Carbonell, Ruben G ^a  

^a North Carolina State University   (United States)

^b NORTH CAROLINA STATE UNIVERSITY   (United States)

^c ProMetic Life Sciences Inc   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMINES; BLOOD; CHEMOTHERAPY; COLUMNS (STRUCTURAL); CONTAMINATION; DRUG THERAPY; ENGINEERING EDUCATION; ENGINEERS; ION EXCHANGE; ION EXCHANGE RESINS; MICROORGANISMS; PEPTIDES; PLASMAS; PROTEINS; RESINS; VIRUSES;

AMERICAN CHEMICAL SOCIETY (ACS); AMERICAN INSTITUTE OF CHEMICAL ENGINEERS (AICHE); COMPLEX MATRICES; HUMAN BLOOD PLASMAS; HUMAN SOURCES; HUMAN THERAPEUTICS; PEPTIDE LIGANDS; PORCINE PARVOVIRUS; PROCESS SOLUTIONS; PRODUCT SAFETY; VIRAL CLEARANCE; VIRUS REMOVAL;

PLASMA (HUMAN);

OLIGOPEPTIDE;

ANIMAL; CONFERENCE PAPER; DRUG MIXTURE; HUMAN; ISOLATION AND PURIFICATION; METABOLISM; PLASMA; PORCINE PARVOVIRUS; VIROLOGY;

ANIMALS; COMPLEX MIXTURES; HUMANS; OLIGOPEPTIDES; PARVOVIRUS, PORCINE; PLASMA;

ANIMALIA; PARVOVIRUS; PORCINE PARVOVIRUS;

EID: 45149103724     PISSN: 87567938     EISSN: None     Source Type: Journal    
DOI: 10.1021/bp070412c     Document Type: Conference Paper

References (42)

1. Huang, P. Y.; Peterson, J. Scaleup and virus clearance studies on virus filtration in monoclonal antibody manufacture. In Membrane Separations in Biotechnology; Wang, W., Ed.; Marcel Dekker: New York, 2001; pp 327-350.
2. Kempf, C.; Stucki, M.; Boschetti, N. Pathogen inactivation and removal procedures used in the production of intravenous immunoglobulins. Biologicals 2007, 35 (1), 35-42.
3. Darling, A. Validation of biopharmaceutical purification processes for virus clearance evaluation. Mol. Biotechnol. 2002, 21 (1), 57-83.
4. Valdes, R.; Ibarra, N.; Ruibal, I.; Beldarrain, A.; Noa, E.; Herrera, N.; Aleman, R.; Padilla, S.; Garcia, J.; Perez, M. Chromatographic removal combined with heat, acid and chaotropic inactivation of four model viruses. J. Biotechnol. 2002, 96 (3), 251.
5. Food and Drug Administration. Points to Consider in the Manufacture and Testing of Monoclonal Antibody Products for Human Use;6 U.S. Department of Health and Human Services: Rockville, MD, 1997.
6. Cai, K.; Gierman, T. M.; Hotta, J.; Stenland, C. J.; Lee, D. C.; Pifat, D. Y.; Petteway, S. R., Jr. Ensuring the biological safety of plasma-derived therapeutic proteins. Biodrugs 2005, 19 (2), 79-96.
7. Furuya, K.; Murai, K.; Yokoyama, T.; Maeno, H.; Takeda, Y.; Murozuka, T.; Wakisaka, A.; Tanifuji, M.; Tomono, T. Implementation of a 20-nm pore-size filter in the plasma-derived factor VIII manufacturing process. Vox Sang. 2006, 91 (2), 119-125.
8. Lute, S.; Bailey, M.; Combs, J.; Sukumar, M.; Brorson, K. Phage passage after extended processing in small-virus-retentive filters. Biotechnol. Appl. Biochem. 2007, 47, 141-151.
9. Wickramasinghe, S. R.; Han, B.; Carlson, J. O.; Powers, S. M. Clearance of minute virus of mice by flocculation and microfiltration. Biotechnol. Bioeng. 2004, 86 (6), 612-621.
10. Yokoyama, T.; Murai, K.; Murozuka, T.; Wakisaka, A.; Tanifuji, M.; Fujii, N.; Tomono, T. Removal of small non-enveloped viruses by nanofiltration. Vox Sang. 2004, 86 (4), 225-229.
11. Specht, R.; Han, B.; Wickramasinghe, S. R.; Carlson, J. O.; Czermak, P.; Wolf, A.; Reif, O.-W. Densonucleosis virus purification by ion exchange membranes. Biotechnol. Bioeng. 2004, 88 (4), 465-473.
12. Zhou, J. X.; Tressel, T.; Gottschalk, U.; Solamo, F.; Pastor, A.; Dermawan, S.; Hong, T.; Reif, O.; Mora, J.; Hutchison, F.; Murphy, M. New Q membrane scale-down model for process-scale antibody purification. J. Chromatogr. A 2006, 1134 (1-2), 66.
13. Phillips, M.; Cormier, J.; Ferrence, J.; Dowd, C.; Kiss, R.; Lutz, H.; Carter, J. Performance of a membrane adsorber for trace impurity removal in biotechnology manufacturing. J. Chromatogr. A 2005, 1078 (1-2), 74.
14. Norling, L.; Lute, S.; Emery, R.; Khuu, W.; Voisard, M.; Xu, Y.; Chen, Q.; Blank, G.; Brorson, K. Impact of multiple re-use of anion-exchange chromatography media on virus removal. J. Chromatogr. A 2005, 1069 (1), 79.
15. Gregori, L.; Lambert, B. C.; Gurgel, P. V.; Gheorghiu, L.; Edwardson, P.; Lathrop, J. T.; MacAuley, C.; Carbonell, R. G.; Burton, S. J.; Hammond, D.; Rohwer, R. G. Reduction of transmissible spongiform encephalopathy infectivity from human red blood cells with prion protein affinity ligands. Transfusion 2006, 46 (7), 1152-1161.
16. Gregori, L.; Gurgel, P. V.; Lathrop, J. T.; Edwardson, P.; Lambert, B. C.; Carbonell, R. G.; Burton, S. J.; Hammond, D. J.; Rohwer, R. G. Reduction in infectivity of endogenous transmissible spongiform encephalopathies present in blood by adsorption to selective affinity resins. Lancet 2006, 368 (9554), 2226-2230.
17. Wang, G.; Carbonell, R. G. Characterization of a peptide affinity support that binds selectively to staphylococcal enterotoxin B. J. Chromatogr. A 2005, 1078, 98-112.
18. Mondorf, K.; Kaufman, D. B.; Carbonell, R. G. Screening of combinatorial peptide libraries: Identification of ligands for affinity purification of proteins using a radiological approach. J. Pept. Res. 1998, 52, 526-536.
19. Yang, H.; Gurgel, P. V.; Carbonell, R. G. Hexamer peptide affinity resins that bind the Fc region of human immunoglobulin G. J. Pept. Res. 2005, 66, 120-137.
20. Wang, G.; De, J.; Schoeniger, J. S.; Roe, D. C.; Carbonell, R. G. A hexamer peptide ligand that binds selectively to staphylococcal enterotoxin B: isolation from a solid phase combinatorial library. J. Pept. Res. 2004, 64 (2), 51-64.
21. Gurgel, P. V.; Carbonell, R. G.; Swaisgood, H. E. Identification of peptide ligands generated by combinatorial chemistry that bind alpha-lactalbumin. Sep. Sci. Technol. 2001, 36 (11), 2411-2431.
22. Heldt, C. L.; Hernandez, R.; Mudiganti, U.; Gurgel, P. V.; Brown, D. T.; Carbonell, R. G. A colorimetric assay for viral agents that produce cytopathic effects. J. Virol. Methods 2006, 135 (1), 56.
23. Furka, A.; Sebestyen, F.; Asgedom, M.; Dibo, G. General-method for rapid synthesis of multicomponent peptide mixtures. Int. J. Pept. Protein Res. 1991, 37 (6), 487-493.
24. Kaufman, D. B.; Hentsch, M. E.; Baumbach, G. A.; Buettner, J. A.; Dadd, C. A.; Huang, P. Y.; Hammond, D. H.; Carbonell, R. G. Affinity purification of fibrinogen using a ligand from a peptide library. Biotechnol. Bioeng. 2002, 77 (3), 278-289.
25. Gurgel, P. V.; Carbonell, R. G.; Swaisgood, H. E. Fractionation of whey proteins with a hexapeptide ligand affinity resin. Bioseparations 2001, 9, 385-392.
26. Ohtsuka, K.; Uemura, K.; Nojima, T.; Waki, M.; Takenaka, S. Immobiliation of RNase S-Peptide on a single-stranded DNA-fixed gold surface and effective masking of its surface by an acridinyl poly(ethylene glycol). Analyst 2006, 131 (1), 55-61.
27. Leckband, D. E.; Kuhl, T.; Wang, H. K.; Herron, J.; Muller, W.; Ringsdorf, H. 4-4-20 anti-fluorescyl IgG Fab′ recognition of membrane bound hapten: Direct evidence for the role of protein and interfacial structure. Biochemistry 1995, 34, 11467-11478.
28. Soltys, P. J.; Etzel, M. R. Equilibrium adsorption of LDL and gold immunoconjugates to affinity membranes containing PEG spacers. Biomaterials 2000, 21, 37-48.
29. Weimer, B. C.; Walsh, M. K.; Wang, X. Influence of a polyethylene glycol spacer on antigen capture by immobilized antibodies. J. Biochem. Biophys. Methods 2000, 45 (2), 211.
30. Simpson, A. A.; Herbert, B.; Sullivan, G. M.; Parrish, C. R.; Zadori, Z.; Tijssen, P.; Rossmann, M. G. The structure of porcine parvovirus: Comparison with related viruses. J. Mol. Biol. 2002, 315, 1189-1198.
31. Weichert, W. S.; Parker, J. S. L.; Wahid, A. T. M.; Chang, S.-F.; Meier, E.; Parrish, C. R. Assaying for structural variation in the parvovirus capsid and its role in infection. Virology 1998, 250 (1), 106.
32. Ali, N. A.; Hasan, A. R.; Wong, L. Y. Development of a novel aymmetric ultra low pressure membranes and a preliminary study for bacteria and pathogen removal applications. Desalination 2007, 206, 474-484.
33. Vaidya, S. R.; Kharul, U. K.; Chitambar, S. D.; Wanjale, S. D.; Bhole, Y. S. Removal of hepatitis A virus from water by polyacrylonitrile-based ultrafiltration membranes. J. Virol. Methods 2004, 119 (1), 7-9.
34. Sano, D.; Ueki, Y.; Watanabe, T.; Omura, T. Membrane separation of indigenous noroviruses from sewage sludge and treated waste-water. Water Sci. Technol. 2006, 54 (3), 77-82.
35. Shukla, A. A.; Hubbard, B.; Tressel, T.; Guhan, S.; Low, D. Downstream processing of monoclonal antibodies - Application of platform approaches. J. Chromatogr. B 2007, 848 (1), 28.
36. Kim, I. S.; Choi, Y. W.; Lee, S. R.; Woo, H. S.; Lee, S. Removal and inactivation of viruses during manufacture of a high purity antihemophilic factor VIII concentrate from human plasma. J. Microbiol. Biotechnol. 2001, 11 (3), 497-503.
37. Li, M.; Wang, Y. S.; Li, W. J.; Su, Z. G. Stability of tumor necrosis factor-alpha during ion exchange chromatography. Biotechnol. Lett. 2003, 25 (11), 905-908.
38. Sugihara, A.; Senoo, T.; Enoki, A.; Shimada, Y.; Nagao, T.; Tominaga, Y. Purification and characterization of a lipase from Pichia burtonii. Appl. Microbiol. Biotechnol. 1995, 43 (2), 277-281.
39. Oscarsson, S. Factors affecting protein interaction at sorbent interfaces. J. Chromatogr., B: Biomed. Sci. Appl. 1997, 699 (1-2), 117.
40. Berkowitz, S. A.; Philo, J. S. Monitoring the homogeneity of adenovirus preparations (a gene therapy delivery system) using analytical ultracentrifugation. Anal. Biochem. 2007, 362 (1), 16-37.
41. Frank, R. Spot-synthesis: an easy technique for the positionally addressable, parallel chemical synthesis on a membrane support. Tetrahedron 1992, 48 (42), 9217.
42. Reichl, U. Antibody epitope mapping using arrays of synthetic peptides. In Antibody Engineering: Methods and Protocols; Lo, B. K. C., Ed.; Humana Press Inc: Totowa, NJ, 2004; Vol. 248.